mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
-0.044 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |